## Summary

I've completed the winsorizing analysis using R and flexsurv. Here are the key findings:

**Best Strategy: Exclude Problem Variable Outliers**
- **18.9% average coefficient difference** (improvement from 24.6% baseline)
- Removes observations where any of the 5 problem variables exceed 99th percentile
- Retains 95.1% of sample (n=9,443 vs 9,926)

**Key Insights:**
1. **Glucose winsorizing alone** helps significantly - 5th/95th percentiles reduced average error from 24.6% to 19.3%
2. **Excluding extreme outliers** works better than winsorizing - probably because extreme values genuinely indicate different populations
3. **Persistent gaps remain** in glucose (39% off), lymph (32% off), and alp (30% off) even after best treatment

The analysis suggests that extreme outliers are a significant source of the discrepancy with Levine 2018, but substantial gaps remain that likely require investigation into data preprocessing differences, measurement units, or model specifications used in the original paper.

The complete R script and detailed results are saved in the research_agents directory for further analysis.
 biomarkers at 1st/99th**: 21.2% avg diff (3.4pp improvement)
- **All biomarkers at 0.5th/99.5th**: 22.3% avg diff (2.3pp improvement)

### 4. Glucose Clinical Thresholds
- **Cap at 20 mmol/L**: 24.6% avg diff (no change - no values exceeded this)
- **Cap at 15 mmol/L**: 24.5% avg diff (minimal improvement)
- **Cap at 11.1 mmol/L (diabetes threshold)**: 22.2% avg diff (2.4pp improvement)

### 5. Exclusion Strategies
- **Exclude glucose >11.1 mmol/L**: 21.8% avg diff (2.8pp improvement), n=9,739
- **Exclude any problem var >99th percentile**: 18.9% avg diff (**5.7pp improvement**), n=9,443

## Key Findings

### 🏆 Best Strategy: Exclude Problem Variable Outliers
**Excluding observations with any problem variable >99th percentile**
- **18.9% average coefficient difference** (5.7 percentage point improvement)
- Sample size: n=9,443 (95.1% retained), 1,640 deaths
- Removes 483 observations with extreme values

### 🥈 Runner-up: Glucose 5th/95th Winsorizing
**Winsorizing glucose at 5th/95th percentiles**
- **19.3% average coefficient difference** (5.3pp improvement)
- Retains full sample size
- Glucose coefficient improves from 46.5% to 10.6% difference

### Persistent Problem Variables
Even with best strategy (exclude outliers), these variables remain problematic:
- **glucose_mmol**: Still 39.1% off (vs 46.5% baseline)
- **lymph**: Still 31.6% off (vs 48.3% baseline)  
- **alp**: Still 30.1% off (vs 44.0% baseline)

### Variables That Respond Well
- **mcv**: Gets very close with most strategies (<1% difference)
- **age**: Consistently <1% difference across all strategies
- **creat_umol**: Often <2% difference
- **lncrp**: Often <5% difference

## Recommendations

1. **Primary recommendation**: Use exclusion strategy removing observations with any problem variable >99th percentile for best overall improvement (18.9% vs 24.6% baseline)

2. **Alternative**: If full sample size is required, use glucose 5th/95th winsorizing (19.3% avg difference)

3. **Further investigation needed**: The persistent large differences in glucose, lymph, and alp suggest either:
   - Different data preprocessing in Levine 2018
   - Different model specifications
   - Measurement/unit differences
   - Different sample selection criteria

4. **Next steps**: Consider investigating data transformation, different biomarker definitions, or alternative model specifications to close the remaining gaps.

## Technical Notes
- All analyses used R flexsurv package with Gompertz distribution
- Winsorizing used quantile-based thresholds with pmin/pmax capping
- Results show coefficient values, Levine target values, and percentage differences
- Gamma parameter differences ranged from 4.1% to 8.0% across strategies
